72 related articles for article (PubMed ID: 16535856)
1. [Preventive effect of trans-resveratrol on hypertension-induced cardiac hypertrophy in partially nephrectomized rats].
Liu ZP; Song Y; Liu ZQ; Zhang XP
Wei Sheng Yan Jiu; 2005 Nov; 34(6):756-8. PubMed ID: 16535856
[TBL] [Abstract][Full Text] [Related]
2. Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model.
Liu Z; Song Y; Zhang X; Liu Z; Zhang W; Mao W; Wang W; Cui W; Zhang X; Jia X; Li N; Han C; Liu C
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1049-54. PubMed ID: 16445570
[TBL] [Abstract][Full Text] [Related]
3. [Adenosine receptors agonists mitigated PAH of rats induced by chronic hypoxia through reduction of renin activity/angiotensin II levels and increase of inducible nitric oxide synthase-nitric oxide levels].
Tan JX; Huang XL; Wang B; Fang X; Huang DN
Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):782-7. PubMed ID: 23302571
[TBL] [Abstract][Full Text] [Related]
4. Activation of SUR2B/Kir6.1 subtype of adenosine triphosphate-sensitive potassium channel improves pressure overload-induced cardiac remodeling via protecting endothelial function.
Tang Y; Long CL; Wang RH; Cui W; Wang H
J Cardiovasc Pharmacol; 2010 Oct; 56(4):345-53. PubMed ID: 20505525
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.
Dolinsky VW; Chakrabarti S; Pereira TJ; Oka T; Levasseur J; Beker D; Zordoky BN; Morton JS; Nagendran J; Lopaschuk GD; Davidge ST; Dyck JR
Biochim Biophys Acta; 2013 Oct; 1832(10):1723-33. PubMed ID: 23707558
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure.
Thandapilly SJ; Wojciechowski P; Behbahani J; Louis XL; Yu L; Juric D; Kopilas MA; Anderson HD; Netticadan T
Am J Hypertens; 2010 Feb; 23(2):192-6. PubMed ID: 19942861
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
Bai H; Wu LL; Xing DQ; Liu J; Zhao YL
Chin Med J (Engl); 2004 Jan; 117(1):88-93. PubMed ID: 14733781
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
Iglarz M; Touyz RM; Viel EC; Paradis P; Amiri F; Diep QN; Schiffrin EL
Hypertension; 2003 Oct; 42(4):737-43. PubMed ID: 12860836
[TBL] [Abstract][Full Text] [Related]
9. Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats.
Thandapilly SJ; Louis XL; Behbahani J; Movahed A; Yu L; Fandrich R; Zhang S; Kardami E; Anderson HD; Netticadan T
Hypertens Res; 2013 Oct; 36(10):866-72. PubMed ID: 23784505
[TBL] [Abstract][Full Text] [Related]
10. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective effect of polydatin on ventricular remodeling after myocardial infarction in coronary artery ligation rats.
Gao Y; Gao J; Chen C; Wang H; Guo J; Wu R
Planta Med; 2015 May; 81(7):568-77. PubMed ID: 25905591
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol ameliorates cardiac dysfunction induced by pressure overload in rats via structural protection and modulation of Ca(2+) cycling proteins.
Dong Q; Wu Z; Li X; Yan J; Zhao L; Yang C; Lu J; Deng J; Chen M
J Transl Med; 2014 Nov; 12():323. PubMed ID: 25425099
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes.
Biala A; Tauriainen E; Siltanen A; Shi J; Merasto S; Louhelainen M; Martonen E; Finckenberg P; Muller DN; Mervaala E
Blood Press; 2010 Jun; 19(3):196-205. PubMed ID: 20429690
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure.
Haller ST; Kennedy DJ; Shidyak A; Budny GV; Malhotra D; Fedorova OV; Shapiro JI; Bagrov AY
Am J Hypertens; 2012 Jun; 25(6):690-6. PubMed ID: 22378033
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol arrests and regresses the development of pressure overload- but not volume overload-induced cardiac hypertrophy in rats.
Wojciechowski P; Juric D; Louis XL; Thandapilly SJ; Yu L; Taylor C; Netticadan T
J Nutr; 2010 May; 140(5):962-8. PubMed ID: 20335634
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
[TBL] [Abstract][Full Text] [Related]
17. ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy.
Adiarto S; Heiden S; Vignon-Zellweger N; Nakayama K; Yagi K; Yanagisawa M; Emoto N
Life Sci; 2012 Oct; 91(13-14):651-7. PubMed ID: 22365964
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 and its binding sites are upregulated in pressure overload cardiac hypertrophy.
Arai M; Yoguchi A; Iso T; Takahashi T; Imai S; Murata K; Suzuki T
Am J Physiol; 1995 May; 268(5 Pt 2):H2084-91. PubMed ID: 7771559
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway.
Wang S; Wang X; Yan J; Xie X; Fan F; Zhou X; Han L; Chen J
Eur J Pharmacol; 2007 Jul; 567(1-2):26-35. PubMed ID: 17499237
[TBL] [Abstract][Full Text] [Related]
20. Possible role of nitric oxide in the protective effect of resveratrol in 5/6th nephrectomized rats.
Chander V; Chopra K
J Surg Res; 2006 Jun; 133(2):129-35. PubMed ID: 16325855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
